Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Baldini

Showing results (71-80 of 151) with videos related to

Pageof 16
Sort By:
Hematological Oncology|June 5, 2020
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphomaRaffaella Marcheselli, Alessia Bari, Tamar Tadmor, et al.
Frontiers in Oncology|April 1, 2021
Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort StudyDaniele Cattaneo, Giorgio Alberto Croci, Cristina Bucelli, et al.
Medical Physics|January 31, 2026
First experimental characterization of a low-pressure nitrogen filled parallel-plate ionization chamber for UHDP electron beam dosimetryMarco Montefiori, Luca Baldini, Maria Giuseppina Bisogni, et al.
Clinical and Experimental Medicine|March 5, 2024
Whole-exome sequencing is feasible on a fresh-frozen skin sample of intravascular large B cell lymphomaFilippo Bagnoli, Giuditta Pini, Bachisio Ziccheddu, et al.
European Journal of Haematology|April 23, 2010
The clinical and biological features of a series of immunophenotypic variant of B-CLLLilla Cro, Andrea Ferrario, Marta Lionetti, et al.
Oncotarget|June 20, 2015
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activationMarta Lionetti, Marzia Barbieri, Katia Todoerti, et al.
Current Drug Targets|August 12, 2009
First-line treatment of multiple myeloma in elderly patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) multiple myeloma working party perspectivePellegrino Musto, Fiorella D'Auria, Giuseppe Pietrantuono, et al.
Annals of Hematology|April 20, 2023
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohortDaniele Cattaneo, Cristina Bucelli, Alfredo Marchetti, et al.
Oncogene|March 1, 2005
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myelomaMichela Mattioli, Luca Agnelli, Sonia Fabris, et al.
Acta Haematologica|November 8, 2016
A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-UpAlessia Bari, Raffaella Marcheselli, Luigi Marcheselli, et al.
Pageof 16

Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
Hematological Oncology|June 5, 2020
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphomaRaffaella Marcheselli, Alessia Bari, Tamar Tadmor, et al.
Frontiers in Oncology|April 1, 2021
Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort StudyDaniele Cattaneo, Giorgio Alberto Croci, Cristina Bucelli, et al.
Medical Physics|January 31, 2026
First experimental characterization of a low-pressure nitrogen filled parallel-plate ionization chamber for UHDP electron beam dosimetryMarco Montefiori, Luca Baldini, Maria Giuseppina Bisogni, et al.
Clinical and Experimental Medicine|March 5, 2024
Whole-exome sequencing is feasible on a fresh-frozen skin sample of intravascular large B cell lymphomaFilippo Bagnoli, Giuditta Pini, Bachisio Ziccheddu, et al.
European Journal of Haematology|April 23, 2010
The clinical and biological features of a series of immunophenotypic variant of B-CLLLilla Cro, Andrea Ferrario, Marta Lionetti, et al.
Oncotarget|June 20, 2015
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activationMarta Lionetti, Marzia Barbieri, Katia Todoerti, et al.
Current Drug Targets|August 12, 2009
First-line treatment of multiple myeloma in elderly patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) multiple myeloma working party perspectivePellegrino Musto, Fiorella D'Auria, Giuseppe Pietrantuono, et al.
Annals of Hematology|April 20, 2023
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohortDaniele Cattaneo, Cristina Bucelli, Alfredo Marchetti, et al.
Oncogene|March 1, 2005
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myelomaMichela Mattioli, Luca Agnelli, Sonia Fabris, et al.
Acta Haematologica|November 8, 2016
A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-UpAlessia Bari, Raffaella Marcheselli, Luigi Marcheselli, et al.
Pageof 16